William Richard White, Chief Financial Officer at Akero Therapeutics, Inc. (AKRO), sold 321,419 shares at $27.66 ($8.7M) on 2024-07-25, disclosed to the SEC on 2024-07-25.
Scheduled sale ($8.7M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.01 | 500 | $14K | 0.2% |
| 2 | $26.71 | 59,637 | $1.6M | 18.3% |
| 3 | $26.71 | 59,637 | $1.6M | 18.3% |
| 4 | $27.19 | 79,446 | $2.2M | 24.8% |
| 5 | $27.19 | 79,446 | $2.2M | 24.8% |
| 6 | $27.00 | 1,791 |
| $48K |
| 0.6% |
| 7 | $27.66 | 20,481 | $567K | 6.5% |
| 8 | $27.66 | 20,481 | $567K | 6.5% |
| Total | $27.07 avg | 321,419 | $8.7M | 100% |
| Filing → |
| AKRO | SELL | 2025-06-12 | $151K | — | Filing → |
| AKRO | SELL | 2025-03-14 | $30K | — | Filing → |
| AKRO | SELL | 2024-12-12 | $173K | — | Filing → |